Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment

被引:42
作者
Kittel, C [1 ]
Ferko, B [1 ]
Kurz, M [1 ]
Voglauer, R [1 ]
Sereinig, S [1 ]
Romanova, J [1 ]
Stiegler, G [1 ]
Katinger, H [1 ]
Egorov, A [1 ]
机构
[1] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, A-1190 Vienna, Austria
关键词
D O I
10.1128/JVI.79.16.10672-10677.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Engineering of the influenza A virus NS1 protein became an attractive approach to the development of influenza vaccine vectors since it can tolerate large inserts of foreign proteins. However, influenza virus vectors expressing long foreign sequences from the NS1 open reading frame (ORF) are usually replication deficient in animals due to the abrogation of their NS1 protein function. In this study, we describe a bicistronic expression strategy based on the insertion of an overlapping UAAUG stop-start codon cassette into the NS gene, allowing the reinitiation of translation of a foreign sequence. Although the expression level of green fluorescent protein (GFP) from the newly created reading frame was significantly lower than that obtained previously from an influenza virus vector expressing GFP from the NS1 ORF, the bicistronic vector appeared to be replication competent in mice and showed outstanding genetic stability. All viral isolates derived from mouse lungs at 10 days postinfection were still capable of expressing GFP in infected cells. Utilizing this bicistronic approach, we constructed another recombinant influenza virus, allowing the secretion of biologically active human interleukin-2 (IL-2). Although this virus also replicated to high titers in mouse lungs, it did not display any mortality rate in infected animals, in contrast to control viruses. Moreover, the IL-2-expressing virus showed an enhanced CD8(+) response to viral antigens in mice after a single intranasal immunization. These results indicate that influenza viruses could be engineered for the expression of biologically active molecules such as cytokines for immune modulation purposes.
引用
收藏
页码:10672 / 10677
页数:6
相关论文
共 35 条
[31]   Generation of recombinant influenza virus using baculovirus delivery vector [J].
Poomputsa, K ;
Kittel, C ;
Egorov, A ;
Ernst, W ;
Grabherr, R .
JOURNAL OF VIROLOGICAL METHODS, 2003, 110 (01) :111-114
[32]   A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFNγ-producing T cells [J].
Power, CA ;
Grand, CL ;
Ismail, N ;
Peters, NC ;
Yurkowski, DP ;
Bretscher, PA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 227 (1-2) :99-107
[33]   RECOVERY OF IMMUNODEFICIENT MICE FROM A VACCINIA VIRUS-IL-2 RECOMBINANT INFECTION [J].
RAMSHAW, IA ;
ANDREW, ME ;
PHILLIPS, SM ;
BOYLE, DB ;
COUPAR, BEH .
NATURE, 1987, 329 (6139) :545-546
[34]   Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice [J].
Takasuka, N ;
Enami, M ;
Itamura, S ;
Takemori, T .
VACCINE, 2002, 20 (11-12) :1579-1585
[35]   Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes [J].
Watanabe, T ;
Watanabe, S ;
Noda, T ;
Fujii, Y ;
Kawaoka, Y .
JOURNAL OF VIROLOGY, 2003, 77 (19) :10575-10583